WHO Urges Rapid Treatment for Concurrent HIV and Mpox
9 Articles
9 Articles
The European Medicines Agency has recommended on Friday the use of lenacapavir in the tools available in the fight against HIV. Presented as "a decisive step forward" by the WHO, it is a treatment...
For more than forty years, the fight against HIV has progressed to the rhythm of major scientific discoveries and logistical or social setbacks. Despite the existing treatments, the virus is still circulating actively in many regions, fueled by inequalities in access to care and difficulties of adherence to daily protocols. In this contrasting landscape, the emergence of preventive treatment for HIV administered in two annual injections upsets p…
Twice-yearly lenacapavir protects against HIV with exceptional efficacy • This injectable prevention replaces daily use of previously required tablets • Key authorities approve the drug, licensing ensures its global availability and impact
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




